ENTITY
Shanghai HeartCare Medical Technology

Shanghai HeartCare Medical Technology (6609 HK)

32
Analysis
Health CareChina
Shanghai HeartCare Medical Technology Corporation Limited develops and manufactures neuro-interventional medical devices. The Company produces ischemic stroke prevention devices, ischemic stroke thrombectomy devices, intracranial stenosis treatment devicies, vacular access devices, and more. Shanghai HeartCare Medical Technology conducts business in China.
more
Refresh
06 Oct 2022 08:29

MicroPort NeuroTech (2172.HK) 22H1 - Advantages Deserve Recognition, but with Overvaluation Risk

NeuroTech has advantages in product richness/quality system, but fierce competition/product homogenization, centralized procurement are major...

Logo
210 Views
Share
04 Jul 2022 08:59

Microport Scientific (853.HK)-The “unique” Development Mode Leads to Lower-Than-Expected Performance

Microport’s 2021 performance missed expectations due to VBP and pandemic. Its “unique” development mode will lead to lower-than...

Logo
304 Views
Share
23 Jun 2022 09:14

Pre-IPO MicroPort NeuroTech - The Industry, the Business and the Concern

NeuroTech's advantages include comprehensive product portfolio with stronger margin/cost control and first-mover advantage.But concerns are on...

Logo
533 Views
Share
21 Mar 2022 09:03

Microport Scientific (853.HK) - The Subsidiaries Would Be a Better Investment

We analyzed the centralized procurement and other concerns on MicroPort. Due to its development mode, the subsidiaries are more attractive and...

Logo
302 Views
Share
07 Feb 2022 20:13

MicroPort NeuroTech IPO: Impressive Product Portfolio Offsets Profitability Concerns

Although Microport's margins have come under pressure, the company has an impressive product portfolio with a majority of them having strong...

Share
x